| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.026 | 0.7 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.042 | 0.5 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.059 | 0.3 |